#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Essential thrombocythaemia Frostbite B precursor type acute leukaemia Meningococcal immunisation Neuromyelitis optica spectrum disorder Gastrointestinal disorder Anti-glomerular basement membrane disease Immune-mediated myositis Insulinoma Hairy cell leukaemia recurrent Mantle cell lymphoma stage III Superficial vein thrombosis Duchenne muscular dystrophy gene carrier Glycogen storage disease type II Glomerulonephritis membranoproliferative More trials…

    Learn about Rare Diseases

    Lymphangiosarcoma – Treatment Medulloblastoma – Treatment Von Willebrand’s disease – Diagnostics Leiomyosarcoma – Diagnostics Congenital generalised lipodystrophy – Diagnostics KBG syndrome – Diagnostics Chordoma – Trials in Disease Cystic fibrosis lung – Life with Disease Combined immunodeficiency – Treatment Friedreich’s ataxia – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cytisinicline F1245/05 Camphor Charcoal, Activated Brexucabtagene Autoleucel ZINC Sodium Butyrate Gr0015 Imifoplatin Nilotinib Ecoo18A VENT-03 Levofloxacin Hemihydrate Netupitant Amikacin Sulfate Goserelin Acetate Forimtamig 4-IODOPHENYLALANINE I-131 Astegolimab Pehero More therapies…

    Learn about Your Condition

    Migraine with aura Microscopic polyangiitis Endocarditis Juvenile idiopathic arthritis Pancreatic carcinoma recurrent Postprandial hypoglycaemia Angina pectoris Magnetic resonance imaging Haemolytic uraemic syndrome Type 1 diabetes mellitus Pneumonia Hyperchylomicronaemia Agitation postoperative Spinal osteoarthritis Arginase deficiency More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study of palonosetron and fosaprepitant to prevent nausea and vomiting after laparoscopic surgery

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Prophylaxis of nausea and vomiting
    Investigated Drugs:
    • Fosaprepitant
    • Ondansetron
    • Palonosetron
    Sweden

  • Testing F-18-AraG imaging scan reliability in patients with lung cancer using repeat scans

    Not yet recruiting

    4 1 1 1
    Investigated Diseases:
    • Lung neoplasm malignant
    Investigated Drugs:
    • Nelarabine
    The Netherlands

  • Study of 6qc-ICG applied to the skin during breast cancer surgery to help surgeons see tumor edges in patients having breast conserving operations

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • 6QC-ICG
    The Netherlands

  • Study of sodium butyrate enemas for bowel function recovery after surgery in children and adults with Hirschsprung’s disease

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Sodium Butyrate
    France

  • Study of sufentanil versus midazolam for pain relief during egg retrieval in women undergoing fertility treatment

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Procedural pain
    Investigated Drugs:
    • Sufentanil
    • Diclofenac Sodium
    • Alprazolam
    Belgium

  • A study comparing 68Ga-FAPI-46 PET scan with standard 18F-FDG PET scan and brain MRI for staging in patients with newly diagnosed non-small cell lung cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
    • Fludeoxyglucose (18F)
    The Netherlands
Previous Page
1 … 753 754 755 756 757 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!